Ask a doctor

Who is the Supplier or Developer of Dysport?

Who is the Supplier or Developer of Dysport?

Doctor Answers 13

Developer of Dysport

Funding for the study was solicited from both Medicis Aesthetics Inc., the maker of Dysport and Allergan Inc., the creator of Botox, but only Medicis Aesthetics funded the study.


New York Dermatologist
4.5 out of 5 stars 8 reviews

Dysport

Medicis is the pharmaceutical company that is bringing Dysport out in the United States. Medicis is a leading dermatological pharmaceutical company that is well respected in the industry. The introduction of Dysport will compete directly with Allergan's Botox, clearly the industry leader. Ultimately, time will tell which product is better based on duration and cost and effect.

Steven Hacker, MD
West Palm Beach Dermatologic Surgeon
5.0 out of 5 stars 4 reviews

Dysport

Dysport is made by Ipsen Pharmaceuticals in Europe and has been brought to the United States by Medicis.  Medicis also provides Restylane and Perlane.    

Sam Naficy, MD
Seattle Facial Plastic Surgeon
5.0 out of 5 stars 170 reviews

Who makes dysport

Dysport is sold by the same company that sells restylane and perlane products. This company's name is Medicis.

Steven Wallach, MD
New York Plastic Surgeon
4.5 out of 5 stars 20 reviews

Who Makes Dysport?

Hi,

Dysport is made by Ipsen Pharmaceuticals in Europe and sold by Medicis in the US who also provide Restylane and Perlane.  Dysport was launched in summer of 2009 and the inital FDA approval was for 50 units to the frown area to last an average of 89 days.  Since we have had experience with Dysport  in the US now for over a year, the amount of units, duration of response, and any side effects have been more clearly delineated.

Grace Liu, MD
Newport Beach Dermatologic Surgeon
5.0 out of 5 stars 37 reviews

Who is the Supplier or Developer of Dysport?

Dysport is made by Ipsen in Europe and distributed here by Medicis, the company that also distributes Restylane and Perlane.  I've used Dysport overseas since 2006 and like it because it has a quicker onset of action in some patients and lasts longer in the crow's feet.  Dysport was approved for use in the US in April of 2009.

Ramtin Kassir, MD
Wayne Facial Plastic Surgeon
4.5 out of 5 stars 56 reviews

Dysport

Dysport is made by Ipsen in Europe and distributed by Medicis here in the United States.  I've been using it in my practice since it was first FDA-approved.

Carmen Kavali, MD
Atlanta Plastic Surgeon
4.5 out of 5 stars 26 reviews

Dysport supplied by Medicis

Dysport is supplied by Medicis Aethetics the same suppliers of Restylane & Perlane. Dysport has been FDA approved since April of 2009.

Vincent N. Zubowicz, MD
Atlanta Plastic Surgeon
4.5 out of 5 stars 16 reviews

Dysport now available in the United States through Medicis

Dysport is a close relative of Botox that is now available in the United States through Medicis. In clinical studies, it has shown to have a faster onset of action than Botox and lasts a little bit longer. The amount of Dysport used is slightly different than the amount of Botox per area. For great results, work with a board-certified plastic surgeon who has a great deal of experience with fillers, Botox and the new Dysport. The price of Dysport will vary by the practice. In our practice, Dysport is somewhat cheaper than Botox. Keep in mind when buying either filler to make sure that you are paying by the unit instead of by the volume (per area, per cc, per ml, etc)
 

Pat Pazmino, MD
Miami Plastic Surgeon
4.5 out of 5 stars 67 reviews

Dysport in the United States

Dysport is available in the US  through Medicis since April 2009 , the company that has provided  us Restylane for years.   In Europe the company is Ipsen and has been available for about nine years.

Lisa Kates, MD
Annapolis Dermatologist
5.0 out of 5 stars 1 review

These answers are for educational purposes and should not be relied upon as a substitute for medical advice you may receive from your physician. If you have a medical emergency, please call 911. These answers do not constitute or initiate a patient/doctor relationship.